To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.
Clinical trial NCT01652209 · COMPLETED
Trial details
- NCT number
- NCT01652209
- Sponsor
- Pharmicell Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2024-08-12
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.